Eli Lilly ٢٠ أبريل ٢٠٢٦ Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? - The Motley Fool
Eli Lilly ٢٠ أبريل ٢٠٢٦ Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics - Pharmaceutical Executive
Eli Lilly ٢٠ أبريل ٢٠٢٦ Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company - investor.lilly.com
Eli Lilly ١٩ أبريل ٢٠٢٦ Eli Lilly nears $2B-plus deal for Kelonia to expand cancer pipeline: WSJ (LLY:NYSE) - Seeking Alpha
Novo Nordisk ١٧ أبريل ٢٠٢٦ Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. - Investor's Business Daily
Endpoints News ٢ أبريل ٢٠٢٦ Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Lonza News ٣١ مارس ٢٠٢٦ Lonza Strengthens Board With Nomination of Former Eli Lilly Executive Stephen Fry - TipRanks
Endpoints News ١٤ مارس ٢٠٢٦ Roche’s breast cancer failure; BioNTech co-founders to depart; Eli Lilly’s quest to stay on top; and more
PharmaVoice ٢٩ يناير ٢٠٢٦ Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential
Endpoints News ١٥ يناير ٢٠٢٦ A compounding pharmacy hits back at Eli Lilly, Novo Nordisk with antitrust lawsuit